top of page

Virtonomy accelerates medtech R&D through in silico simulations, minimizing clinical trials, reducing costs, and mitigating risk of startup failures

The cost – both financial and ethical – of medical device R&D, ranging from early-stage development to running trials in animals and humans is enormous. Failure in later stages of the development pipeline can wipe out tens of millions from bottoms lines, damage reputations, and for startups, can often spell bankruptcy. Virtonomy is a leader in in silico simulations, helping to speed up R&D processes at multiple stages, including reducing the size and length of clinical trials, thus saving medtech companies millions.

In silico simulations, R&D acceleration, AI, Digital Twins, Deep Tech

bottom of page